Levonorgestrel Ethinylestradiol Eugia (Ethinylestradiol, Levonorgestrel)

The ethinylestradiol component activates estrogen receptors, while levonorgestrel binds to progesterone receptors. Together they suppress the hypothalamic‑pituitary‑ovarian axis, preventing the luteinizing hormone surge that triggers ovulation. The progestogen also thickens cervical mucus and alters the uterine lining, creating multiple barriers to fertilization and implantation.

The specific dosing regimen is determined by the prescribing clinician. Typically, the product is taken as one tablet daily at the same time each day, but the exact strength, start day of the cycle, and any missed‑dose instructions are individualized based on the patient’s medical history and the prescriber’s judgment.

This medication is not intended for use during pregnancy and should be discontinued if pregnancy is confirmed. While limited data exist for breastfeeding, most guidelines advise caution; the benefits and risks should be evaluated by the prescriber, and alternative contraception may be recommended during lactation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and necessary import documentation.

Levonorgestrel Ethinylestradiol Eugia contains a standard dose of ethinylestradiol paired with levonorgestrel, offering efficacy comparable to other second‑generation combined pills. Differences among products usually relate to the specific progestogen used, hormone dose, and side‑effect profile; clinicians select a formulation based on individual risk factors and patient preference.

Store the tablets at ambient temperature, preferably below 25 °C, in the original blister pack to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

The medication is taken orally as a single tablet each day, preferably at the same time each day to maintain steady hormone levels. It can be swallowed with or without food, but patients should follow any specific instructions provided by their prescriber regarding missed doses.

The most serious adverse events include thromboembolic disorders such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Rare but severe reactions like anaphylaxis and hepatic adenomas have also been reported. Patients should seek immediate medical attention if they experience unexplained leg pain, shortness of breath, severe headache, or signs of an allergic reaction.

Women with a history of blood‑clotting disorders, estrogen‑dependent cancers, uncontrolled hypertension, severe liver disease, or known hypersensitivity to any component should avoid this product. Additionally, smokers over 35 years of age are advised against using combined oral contraceptives due to heightened cardiovascular risk.